FTRE Earnings Date: Feb 25, 2027 (Estimated) — Fortrea Holdings Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is FTRE's next earnings date?
Fortrea Holdings Inc. (FTRE) is expected to report Q4 2026 earnings on Thursday, February 25, 2027 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.24 on revenue of $676.4M.
How did FTRE do in its last earnings report?
In its most recent report on Oct 29, 2026, Fortrea Holdings Inc. posted EPS of $0.28 versus the $0.22 estimate, a beat of 28.9%. Revenue was $691.5M against a $671.6M estimate.
How much does FTRE stock move after earnings?
FTRE beat EPS estimates in 5 of its last 8 reported quarters. Over the last 7 reports the stock moved an average of 12.7% (up or down) in the day after earnings.
About Fortrea Holdings Inc.
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
🤖 AI Earnings Analysis
FTRE beat estimates, with revenue of $692M topping $672M and EPS of $0.28 exceeding $0.22, but the result is concerning: operating losses reached $330M and margins were -36.2%.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-29 | 0.22 | 0.28 | +28.91% | $691.5M | ✅ Beat | — | — | — | |
| 2026-07-29 | Q2 2026 | 0.18 | 0.23 | +27.78% | $678.2M | ✅ Beat | -1.45% | -13.09% | -10.48% |
| 2026-05-05 | Q1 2026 | 0.05 | 0.16 | +220.00% | $636.5M | ✅ Beat | +18.61% | +22.37% | +27.59% |
| 2026-02-26 | Q4 2025 | 0.16 | 0.09 | -43.75% | $660.5M | ❌ Miss | +4.45% | +0.39% | -7.64% |
| 2025-11-05 | Q3 2025 | 0.16 | 0.12 | -25.00% | $701.3M | ❌ Miss | +23.20% | +21.55% | +49.48% |
| 2025-08-06 | Q2 2025 | 0.07 | 0.19 | +171.43% | $710.3M | ✅ Beat | +0.30% | +11.43% | +60.21% |
| 2025-05-12 | Q1 2025 | -0.07 | 0.02 | +128.57% | $651.3M | ✅ Beat | -15.61% | -27.80% | -12.03% |
| 2025-03-03 | Q4 2024 | 0.37 | 0.18 | -51.35% | $697.0M | ❌ Miss | -25.05% | -22.89% | -45.49% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q3 FY26 · $691.5M total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| North America | 47.1% | $326.0M | -2.0% | $309.5M | $344.3M | $332.7M | $303.1M |
| Europe | 32.1% | $222.2M | +4.2% | $200.3M | $218.7M | $213.2M | $219.5M |
| Other Geographical Areas | 20.7% | $143.3M | -7.8% | $141.5M | $147.3M | $155.4M | $137.9M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.